CME Information
Overview
In the 25 years since the first reports of the disease, AIDS has become a global epidemic. Worldwide, an estimated 38.6 million people are living with HIV, nearly half of them women and girls between the ages of 15 and 24. And though the spread of the virus has slowed in some countries, it has escalated or remained steady in others. In 2005, more than 4 million people were newly infected with HIV; 25 million have died of AIDS since the epidemic began.
Despite improved treatments and better access to care for people in the hardest-hit parts of the world, most experts agree that the pandemic is still in the early stages. With a vaccine probably decades away, the best hope for stemming the spread of HIV now lies in prevention, treatment, and education.
The 11th Annual International Meeting of the Institute of Human Virology will target physicians, scientists and other health care professionals involved in research, patient care, public health, and disease prevention. This meeting provides three full days of continuing educational courses and comprehensive scientific developments in infectious diseases: advances in HIV therapeutics, HIV and lymphoma genesis, controlling replication of human retroviruses, latency updates, Hepatitis C, HIV entry, development of HIV vaccines. pathophysiology, diagnosis, treatment, and prevention.
Target Audience
Clinicians and researchers in infectious disease, internal medicine, microbiology, and retro-virology, as well as health professionals in disease prevention and public health, from a variety of practice settings and work situations worldwide.
Learning Objectives
At the conclusion of this course, participants should be able to:
- Summarize and evaluate progression and anti progression factors in patients with HIV documented infections
- Outline new clinical developments in HIV treatment as they relate to available therapeutics in all medication classes
- Differentiate lymphoma genesis in the context of HIV infection including B-cell activation
- Formulate a hypotheses discussing replication control of the human retroviruses
- Discuss new clinical evidence on HIV viral latency including progression and manipulation
- Identify clinical advances in the treatment of the Hepatitis C virus
- Recall and interpret early events associated with HIV Infection
- Review the HIV therapeutic class of entry inhibitors
- Discuss advances in proteomics in HIV infection and therapeutics
CME Sponsorship
CME Sponsorship
Sponsored by the University of Maryland School of Medicine
Accreditation
Accreditation
The University of Maryland School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Credit Designation
The University of Maryland School of Medicine designates this educational activity for a maximum of 19 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Faculty Disclosure
It is the policy of the University of Maryland School of Medicine to ensure balance, independence, objectivity, and scientific rigor in all of its educational activities. In accordance with this policy, activity faculty are asked to disclose all relevant financial relationships. Any conflicts of interest identified must be resolved prior to presentation of the educational activity.
Acknowledgement of Commercial Support
The 11th Annual International Meeting of the Institute of Human Virology is supported in part by educational grants from commercial supporters. A complete list of commercial supporters will be published in course materials at the time of the conference.
Discussion of Off-Label or Investigational Uses of products
Presentations in this continuing medical education activity may contain references to unlabeled or unapproved uses of drugs or devices. The audience is advised to consult the full prescribing information of all drugs or devices prior to use.
ADA Statement
If you require special accommodations to attend or participate in this CME activity, please provide information about your requirements to at least 5 business days in advance of the activity. Please contact:
Beth Peterson
Assistant to David Wilkins, COO
Institute of Human Virology
University of Maryland School of Medicine
725 West Lombard Street, S307
Baltimore, MD 21201
410-706-1982 Phone (1-800-735-2258 TTY/voice)
410-706-1952 - Fax